Articles of Association

According to the Articles of Association, the Board of Directors of the Company shall have three (3) to six (6) members with a maximum of five (5) deputies. Board members and deputies are elected by the Annual General Meeting. The Board’s assignment is valid until the end of the next Annual General Meeting. The management and all board members can be reached via the Company’s head office at Gasverksgatan 1, 222 29, Lund. The Board’s work is governed by the Swedish Companies Act, the Articles of Association and the rules of procedure produced by the Board.

SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects. 

Facebook Linkedin Envelope

This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.

COOKIE POLICY
Accept